AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile

AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
158 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and cancer, besides infection and neurological diseases. The companys product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies and through distributors and local representative offices. The company markets its products to primary care and specialty care physicians.

AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals i

  
Source:
Document ID
GDME3904D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents26
  List of Tables52
  List of Figures71
AstraZeneca Plc, Medical Equipment, Deals By Year, 2010 to YTD 201672
AstraZeneca Plc, Medical Equipment Deals By Type, 2010 to YTD 201691
AstraZeneca Plc, Medical Equipment, Deals By Region, 2010 to YTD 2016101
AstraZeneca Plc, Medical Equipment, Deals By Market, 2010 to YTD 2016111
AstraZeneca Plc, Medical Equipment, Deals Summary, 2010 to YTD 2016124
AstraZeneca Plc, Medical Equipment, Deal Details1656
  Venture Financing161
    Definiens Raises USD20.3 Million in Venture Financing Round162
    CeraPedics Raises US$19 Million In Series C Financing182
    Definiens Raises US$13 Million In Venture Financing202
    Ambit Biosciences Secures US$30 Million In Series D-2 Financing223
  Partnerships251
    AstraZeneca Enters into Agreement with Genedata251
    Neoprobe Enters Into Licensing Agreement With AstraZeneca262
    AgPlus Diagnostics Enters into Agreement with AstraZeneca281
    Indivumed Partners with Definiens291
    Foundation Medicine Enters into Agreement with AstraZeneca301
    MedImmune Enters into Agreement with Genisphere311
    Definiens Partners with MolecularMD321
    Human Longevity Partners with AstraZeneca331
    PROOF Centre Partners with AstraZeneca341
    Labcyte Enters into Agreement with AstraZeneca351
    HighRes Biosolutions Enters into Agreement with AstraZeneca361
    AstraZeneca Enters into Research Agreement with Sutter Health371
    Myriad Genetics Expands Agreement with AstraZeneca381
    Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System392
    AstraZeneca Enters into Co-Development Agreement with Qiagen411
    AstraZeneca Enters into Co-Development Agreement with Roche421
    Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK431
    Ventana Medical Enters into Co-Development Agreement with MedImmune441
    Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test451
    Myriad Genetics Expands Agreement with AstraZeneca for Olaparib461
    Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery471
    AstraZeneca Enters Into Research Agreement With Karolinska Institutet481
    Metamark Genetics Enters Into Co-Development Agreement With Definiens491
    Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement501
    Leica Microsystems Enters Into Co-Marketing Agreement With Definiens512
    Definiens Enters Into An Agreement With Cernostics531
    Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens541
    Royal Philips Electronics Enters Into Agreement With Definiens551
    aycan Digitalsysteme Enters Into Technology Integration Agreement With Definiens For Software Solution To Detect Lung Tumors561
    Thermo Fisher Scientific, Tokyo Medical University, Lund University And AstraZeneca Form Joint Venture571
    Royal Philips Electronics Signs Agreement With Definiens581
    AstraZeneca Enters Into Co-Development Agreement With Dako Denmark591
  Merger601
    AstraZeneca Rumored To Merge With Amgen601
  Debt Offering611
    AstraZeneca Prices Private Placement of 0.875% Notes Due 2021611
  Acquisition621
    Pfizer May Increase Bid to Acquire AstraZeneca622
    MedImmune Acquires Definiens for USD150 Million642
    AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion661
    Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company672
    AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India691
    DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million702
AstraZeneca Plc - Key Competitors721
Key Employees732
Locations And Subsidiaries756
  Head Office751
  Other Locations &Subsidiaries756
Recent Developments811
Strategy And Business Planning811
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery811
Dec 14, 2015: AZ Investment Gives Local Economy Early Christmas Present821
Sep 11, 2015: AstraZeneca purchases US biologics manufacturing facility to support growing pipeline831
Jul 30, 2015: Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement841
Jun 10, 2015: Vall d Hebron Institute of Oncology and AstraZeneca form an oncology alliance851
Feb 26, 2015: AstraZeneca to create stand-alone company for small molecule early-stage antibiotic R&D861
Financial Announcements871
Jul 28, 2016: AstraZeneca: H1 2016 Results8712
Apr 29, 2016: AstraZeneca announces 1st Quarter 2016 Results9911
Apr 29, 2016: AstraZeneca Announces Q1 2016 Results1102
Feb 04, 2016: Full-Year and Q4 2015 Results1122
Feb 04, 2016: AstraZeneca Full-Year and Q4 2015 Results11411
Jul 30, 2015: AstraZeneca H1 2015 results1257
Apr 24, 2015: AstraZeneca first quarter results 20151328
Feb 05, 2015: AstraZeneca Fourth Quarter And Full Year Results 20141403
Corporate Communications1431
Sep 28, 2016: Change To Astrazeneca Board Of Directors1431
Aug 24, 2015: AstraZeneca appoints Dr Sean Bohen1441
Aug 24, 2015: AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer1451
Jun 16, 2015: AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT1461
Jun 10, 2015: AstraZeneca s Chief Medical Officer To Quit Company1471
Mar 19, 2015: AstraZeneca establishes Scientific Review Board to support clinical trial data transparency commitment1482
Feb 17, 2015: AstraZeneca announces Non-Executive Board changes1501
Product News1511
Apr 17, 2015: Real World Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC1511
Other Significant Developments1521
Sep 21, 2016: AstraZeneca Selects LLamasoft as Supply Chain Design Partner of Choice1521
Jul 23, 2015: Adherium &AstraZeneca Partner to Improve the Lives of Individuals with Respiratory Disease1531
May 18, 2015: AstraZeneca to invest in new biologics manufacturing facility in S dert lje, Sweden, to support accelerating biologics portfolio1541
Mar 26, 2015: Helomics Partners with Leading Global Healthcare Companies to Support The 100,000 Genomes Project1551
Jan 27, 2015: AstraZeneca Chooses Box to Power Enterprise Content Collaboration for All Employees1561
Jan 05, 2015: AstraZeneca Announces Management Changes1571
Appendix1581
  Methodology1581
  About GlobalData1581
  Contact Us1581
  Disclaimer1581

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 03, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/AstraZeneca-Plc-AZN-Medical-Equipment-Deals-and-Alliances-Profile-2148-17540>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/AstraZeneca-Plc-AZN-Medical-Equipment-Deals-and-Alliances-Profile-2148-17540>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research